{"id":154538,"date":"2021-06-04T15:46:16","date_gmt":"2021-06-04T18:46:16","guid":{"rendered":"https:\/\/www.suno.com.br\/noticias\/?p=154538"},"modified":"2021-06-04T15:46:16","modified_gmt":"2021-06-04T18:46:16","slug":"xp-recomenda-compra-hypera-hype3-blau-blau3","status":"publish","type":"post","link":"https:\/\/www.suno.com.br\/noticias\/xp-recomenda-compra-hypera-hype3-blau-blau3\/","title":{"rendered":"XP recomenda compra da Hypera (HYPE3), mas a &#8220;prefer\u00eancia \u00e9 pela Blau&#8221; (BLAU3)"},"content":{"rendered":"<p>Em relat\u00f3rio divulgado nesta quinta-feira (4), a XP anunciou que est\u00e1 iniciando a cobertura do setor farmac\u00eautico brasileiro j\u00e1 com recomenda\u00e7\u00e3o de compra para a<a href=\"https:\/\/www.suno.com.br\/acoes\/blau3\/\"> Blau (BLAU3)<\/a> e para <a class=\"suno-keyword\" style=\"background: greenyellow;\" href=\"https:\/\/www.suno.com.br\/acoes\/HYPE3\/\" target=\"_blank\" rel=\"noopener noreferrer\" data-force=\"yes\" data-priority=\"2\">Hypera (HYPE3)<\/a>.<\/p>\t<div class=\"wrapper-featured-image\">\n\t\t<figure class=\"spotlightImg\">\n\n\t\t\t<picture>\n\t\t\t\t<source media=\"(max-width: 768px)\" srcset=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/04\/49d5915e-about-3887433_1280-400x200.webp\">\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" class=\"newsContent__article__imgCapa lazyloadDisabled \" src=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/04\/49d5915e-about-3887433_1280-800x450.webp\" width=\"800\" height=\"450\" alt=\"XP recomenda compra da Hypera (HYPE3), mas a &#8220;prefer\u00eancia \u00e9 pela Blau&#8221; (BLAU3)\" fetchpriority=high \/>\n\t\t\t<\/picture>\n\n\t\t\t<figcaption class=\"wp-caption-text wp-caption-text--show\">F\u00e1rmaco. Foto: Pixabay<\/figcaption>\n\t\t<\/figure>\n\t<\/div>\n\n\n\t<p>\n\t\t<a href=\"https:\/\/lp.suno.com.br\/planilha-controle-gastos\/\" target=\"_blank\" data-element=\"shortcode-suno-banner\" title=\"Banner SUNO, clique e saiba mais\">\n\t\t\t<picture>\n\t\t\t\t<source media=\"(max-width: 500px)\" srcset=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/400x300-Planilha-controle-de-gastos.png\">\n\t\t\t\t<img class=\"newsContent__article__imgCapa newsContent__article__imgCapa--banner\"\n\t\t\t\t\tsrc=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/1420x240-Planilha-controle-de-gastos.png\"\n\t\t\t\t\tdata-promo-id=\"101751\"\t\t\t\t\t\t\t\t\t\twidth='1420' height='240'\t\t\t\t\talt=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/1420x240-Planilha-controle-de-gastos.png\"\n\t\t\t\t>\n\t\t\t<\/picture>\n\t\t<\/a>\n\t<\/p>\n\n\n<p>Para a Blau, a XP prev\u00ea um <a href=\"https:\/\/www.suno.com.br\/artigos\/preco-alvo\/\">pre\u00e7o-alvo<\/a> de R$ 64 por a\u00e7\u00e3o, enquanto projeta um pre\u00e7o-alvo de R$ 48 por papel da Hypera.<\/p>\n<p>Entretanto, a Blau \u00e9 a preferida pelos analistas Vitor Pini, Matheus Soares e Marcela Ungaretti, que explicam que &#8220;embora tenhamos uma recomenda\u00e7\u00e3o de Compra para ambas as a\u00e7\u00f5es, nossa prefer\u00eancia \u00e9 pela Blau, pois vemos o mercado institucional com maiores barreiras de entrada em rela\u00e7\u00e3o ao varejo devido \u00e0 maior complexidade de seus produtos (principalmente injet\u00e1veis e com grande participa\u00e7\u00e3o de produtos biol\u00f3gicos)&#8221;.<\/p>\n<p><a href=\"https:\/\/lp.suno.com.br\/suno-one\/\">Suno One: acesse gratuitamente eBooks, Minicursos, Artigos e V\u00eddeo Aulas sobre investimentos com um \u00fanico cadastro. Clique para saber mais!<\/a><\/p>\n<p>Assim como a recomenda\u00e7\u00e3o de compra da XP para a Blau, a da Hypera tamb\u00e9m \u00e9 baseada nas perspectivas de crescimento.<\/p>\n<p>Em rela\u00e7\u00e3o ao<strong> setor farmac\u00eautico brasileiro<\/strong>, o relat\u00f3rio da <strong>XP<\/strong> destaca que &#8220;a ind\u00fastria farmac\u00eautica deve continuar se beneficiando de um cen\u00e1rio de crescimento muito positivo e vemos as duas empresas bem posicionadas em seus segmentos &#8211; institucional e varejo, respectivamente &#8211; para aproveitar essa oportunidade de crescimento&#8221;.<\/p>\n\t<p>\n\t\t<a href=\"https:\/\/lp.suno.com.br\/planilha-da-vida-financeira\/\" target=\"_blank\" data-element=\"shortcode-suno-banner\" title=\"Banner SUNO, clique e saiba mais\">\n\t\t\t<picture>\n\t\t\t\t<source media=\"(max-width: 500px)\" srcset=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/04\/400x300-Planilha-vida-financeira-true.png\">\n\t\t\t\t<img class=\"newsContent__article__imgCapa newsContent__article__imgCapa--banner\"\n\t\t\t\t\tsrc=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/04\/1420x240-Planilha-vida-financeira-true.png\"\n\t\t\t\t\tdata-promo-id=\"106682\"\t\t\t\t\t\t\t\t\t\twidth='1420' height='240'\t\t\t\t\talt=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/04\/1420x240-Planilha-vida-financeira-true.png\"\n\t\t\t\t>\n\t\t\t<\/picture>\n\t\t<\/a>\n\t<\/p>\n\n\n<p>O documento lembra que a popula\u00e7\u00e3o brasileira est\u00e1 envelhecendo de maneira r\u00e1pida e que os gastos com sa\u00fade tendem a ser mais elevados para pessoas com mais de 75 anos de idade.<\/p>\n\n\t<div data-element=\"shortcode-read-more\" class=\"readToo\">\n\t\t\t\t<span class=\"readToo__title\">Veja tamb\u00e9m<\/span>\n\t\t\t\t<ul class=\"readToo__list\">\n\t\t\t<li><a href=\"https:\/\/www.suno.com.br\/noticias\/blau-farmaceutica-blau3-lucro-quase-triplica-base-anual\/\">Blau Farmac\u00eautica (BLAU3): Em primeiro balan\u00e7o p\u00f3s-IPO, lucro quase triplica na base anual<\/a><\/li><li><a href=\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-lucro-1t21\/\">Hypera Pharma (HYPE3): lucro l\u00edquido sobe 28,1% no 1T21 para R$ 305,1 mi<\/a><\/li>\t\t<\/ul>\n\t<\/div>\n\n\n<p>Al\u00e9m disso, para os analistas, o fato da ind\u00fastria farmac\u00eautica brasileira concentrar os esfor\u00e7os de desenvolvimento de produtos em medicamentos gen\u00e9ricos, com menor gasto em P&amp;D e menor risco de execu\u00e7\u00e3o, \u00e9 outro aspecto importante.<\/p>\n<h2>Cota\u00e7\u00e3o da Blau e da Hypera<\/h2>\n<p>Por volta das 15h30 dessa sexta-feira (4) a <a href=\"https:\/\/www.suno.com.br\/artigos\/tipos-de-acoes\/\">a\u00e7\u00e3o<\/a> da Hypera (HYPE3) operava em queda de 1,10%, valendo R$ 35,83. Por sua vez, o papel da<strong> Blau (BLAU3)<\/strong> estava sendo negociado em alta de 1,27%, cotado a R$ 47,95.<\/p>\n\t<p>\n\t\t<a href=\"https:\/\/lp.suno.com.br\/planilha-de-controle-de-investimentos\/\" target=\"_blank\" data-element=\"shortcode-suno-banner\" title=\"Banner SUNO, clique e saiba mais\">\n\t\t\t<picture>\n\t\t\t\t<source media=\"(max-width: 500px)\" srcset=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/400x300-Controle-de-Investimentos.png\">\n\t\t\t\t<img class=\"newsContent__article__imgCapa newsContent__article__imgCapa--banner\"\n\t\t\t\t\tsrc=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/1420x240-Controle-de-Investimentos.png\"\n\t\t\t\t\tdata-promo-id=\"75934\"\t\t\t\t\t\t\t\t\t\twidth='1420' height='240'\t\t\t\t\talt=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/1420x240-Controle-de-Investimentos.png\"\n\t\t\t\t>\n\t\t\t<\/picture>\n\t\t<\/a>\n\t<\/p>\n\n\n","protected":false},"excerpt":{"rendered":"<p>Em relat\u00f3rio divulgado nesta quinta-feira (4), a XP anunciou que est\u00e1 iniciando a cobertura do setor farmac\u00eautico brasileiro j\u00e1 com recomenda\u00e7\u00e3o de compra para a Blau (BLAU3) e para Hypera (HYPE3). Hypera (HYPE3). Foto Divulga\u00e7\u00e3o Para a Blau, a XP prev\u00ea um pre\u00e7o-alvo de R$ 64 por a\u00e7\u00e3o, enquanto projeta um pre\u00e7o-alvo de R$ 48 [&hellip;]<\/p>\n","protected":false},"author":39,"featured_media":137378,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[64],"tags":[106070,105816,501,888],"suno_strategy":[],"class_list":["post-154538","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-negocios","tag-blau-farmaceutica-blau3","tag-especialistas","tag-hypera-pharma-hype3","tag-xp-investimentos"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>XP recomenda compra da Hypera, mas a &quot;prefer\u00eancia \u00e9 pela Blau&quot;<\/title>\n<meta name=\"description\" content=\"A XP inicia a cobertura do setor farmac\u00eautico brasileiro, com recomenda\u00e7\u00e3o de compra para a Blau (BLAU3) e Hypera (HYPE3). Clique e saiba mais\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.suno.com.br\/noticias\/xp-recomenda-compra-hypera-hype3-blau-blau3\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"XP recomenda compra da Hypera, mas a &quot;prefer\u00eancia \u00e9 pela Blau&quot;\" \/>\n<meta property=\"og:description\" content=\"A XP inicia a cobertura do setor farmac\u00eautico brasileiro, com recomenda\u00e7\u00e3o de compra para a Blau (BLAU3) e Hypera (HYPE3). Clique e saiba mais\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.suno.com.br\/noticias\/xp-recomenda-compra-hypera-hype3-blau-blau3\/\" \/>\n<meta property=\"og:site_name\" content=\"Suno Not\u00edcias\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/sunoresearch\" \/>\n<meta property=\"og:image\" content=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/04\/49d5915e-about-3887433_1280.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Laura Moutinho\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@sunoresearch\" \/>\n<meta name=\"twitter:site\" content=\"@sunoresearch\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Laura Moutinho\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/xp-recomenda-compra-hypera-hype3-blau-blau3\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/xp-recomenda-compra-hypera-hype3-blau-blau3\/\"},\"author\":{\"name\":\"Laura Moutinho\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/3df0d2808748b74496efe5dbeaef2c72\"},\"headline\":\"XP recomenda compra da Hypera (HYPE3), mas a &#8220;prefer\u00eancia \u00e9 pela Blau&#8221; (BLAU3)\",\"datePublished\":\"2021-06-04T18:46:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/xp-recomenda-compra-hypera-hype3-blau-blau3\/\"},\"wordCount\":370,\"publisher\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/xp-recomenda-compra-hypera-hype3-blau-blau3\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/04\/49d5915e-about-3887433_1280-jpg.webp\",\"keywords\":[\"Blau Farmac\u00eautica (BLAU3)\",\"Especialistas\",\"Hypera Pharma (HYPE3)\",\"XP Investimentos\"],\"articleSection\":[\"Neg\u00f3cios\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/xp-recomenda-compra-hypera-hype3-blau-blau3\/\",\"url\":\"https:\/\/www.suno.com.br\/noticias\/xp-recomenda-compra-hypera-hype3-blau-blau3\/\",\"name\":\"XP recomenda compra da Hypera, mas a \\\"prefer\u00eancia \u00e9 pela Blau\\\"\",\"isPartOf\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/xp-recomenda-compra-hypera-hype3-blau-blau3\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/xp-recomenda-compra-hypera-hype3-blau-blau3\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/04\/49d5915e-about-3887433_1280-jpg.webp\",\"datePublished\":\"2021-06-04T18:46:16+00:00\",\"description\":\"A XP inicia a cobertura do setor farmac\u00eautico brasileiro, com recomenda\u00e7\u00e3o de compra para a Blau (BLAU3) e Hypera (HYPE3). Clique e saiba mais\",\"breadcrumb\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/xp-recomenda-compra-hypera-hype3-blau-blau3\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.suno.com.br\/noticias\/xp-recomenda-compra-hypera-hype3-blau-blau3\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/xp-recomenda-compra-hypera-hype3-blau-blau3\/#primaryimage\",\"url\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/04\/49d5915e-about-3887433_1280-jpg.webp\",\"contentUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/04\/49d5915e-about-3887433_1280-jpg.webp\",\"width\":1280,\"height\":853,\"caption\":\"F\u00e1rmaco. Foto: Pixabay\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/xp-recomenda-compra-hypera-hype3-blau-blau3\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Not\u00edcias\",\"item\":\"https:\/\/www.suno.com.br\/noticias\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neg\u00f3cios\",\"item\":\"https:\/\/www.suno.com.br\/noticias\/negocios\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"XP recomenda compra da Hypera (HYPE3), mas a &#8220;prefer\u00eancia \u00e9 pela Blau&#8221; (BLAU3)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#website\",\"url\":\"https:\/\/www.suno.com.br\/noticias\/\",\"name\":\"Suno Not\u00edcias\",\"description\":\"Seu portal de informa\u00e7\u00e3o sobre o mundo dos investimentos\",\"publisher\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.suno.com.br\/noticias\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#organization\",\"name\":\"Suno Not\u00edcias\",\"url\":\"https:\/\/www.suno.com.br\/noticias\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png\",\"contentUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png\",\"width\":180,\"height\":180,\"caption\":\"Suno Not\u00edcias\"},\"image\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/facebook.com\/sunoresearch\",\"https:\/\/x.com\/sunoresearch\",\"https:\/\/www.instagram.com\/suno\",\"https:\/\/www.linkedin.com\/company\/suno-research\/\",\"https:\/\/www.youtube.com\/c\/sunoresearch\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/3df0d2808748b74496efe5dbeaef2c72\",\"name\":\"Laura Moutinho\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7571c7c8ca3a6fca5e41384ece5557ff?s=96&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7571c7c8ca3a6fca5e41384ece5557ff?s=96&r=g\",\"caption\":\"Laura Moutinho\"},\"description\":\"Estagi\u00e1ria na Suno Not\u00edcias, escreve not\u00edcias que afetam o mercado financeiro. Estuda administra\u00e7\u00e3o na Universidade Presbiteriana Mackenzie.\",\"url\":\"https:\/\/www.suno.com.br\/noticias\/author\/laura-moutinho\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"XP recomenda compra da Hypera, mas a \"prefer\u00eancia \u00e9 pela Blau\"","description":"A XP inicia a cobertura do setor farmac\u00eautico brasileiro, com recomenda\u00e7\u00e3o de compra para a Blau (BLAU3) e Hypera (HYPE3). Clique e saiba mais","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.suno.com.br\/noticias\/xp-recomenda-compra-hypera-hype3-blau-blau3\/","og_locale":"pt_BR","og_type":"article","og_title":"XP recomenda compra da Hypera, mas a \"prefer\u00eancia \u00e9 pela Blau\"","og_description":"A XP inicia a cobertura do setor farmac\u00eautico brasileiro, com recomenda\u00e7\u00e3o de compra para a Blau (BLAU3) e Hypera (HYPE3). Clique e saiba mais","og_url":"https:\/\/www.suno.com.br\/noticias\/xp-recomenda-compra-hypera-hype3-blau-blau3\/","og_site_name":"Suno Not\u00edcias","article_publisher":"https:\/\/facebook.com\/sunoresearch","og_image":[{"width":1280,"height":853,"url":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/04\/49d5915e-about-3887433_1280.jpg","type":"image\/jpeg"}],"author":"Laura Moutinho","twitter_card":"summary_large_image","twitter_creator":"@sunoresearch","twitter_site":"@sunoresearch","twitter_misc":{"Escrito por":"Laura Moutinho","Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.suno.com.br\/noticias\/xp-recomenda-compra-hypera-hype3-blau-blau3\/#article","isPartOf":{"@id":"https:\/\/www.suno.com.br\/noticias\/xp-recomenda-compra-hypera-hype3-blau-blau3\/"},"author":{"name":"Laura Moutinho","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/3df0d2808748b74496efe5dbeaef2c72"},"headline":"XP recomenda compra da Hypera (HYPE3), mas a &#8220;prefer\u00eancia \u00e9 pela Blau&#8221; (BLAU3)","datePublished":"2021-06-04T18:46:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.suno.com.br\/noticias\/xp-recomenda-compra-hypera-hype3-blau-blau3\/"},"wordCount":370,"publisher":{"@id":"https:\/\/www.suno.com.br\/noticias\/#organization"},"image":{"@id":"https:\/\/www.suno.com.br\/noticias\/xp-recomenda-compra-hypera-hype3-blau-blau3\/#primaryimage"},"thumbnailUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/04\/49d5915e-about-3887433_1280-jpg.webp","keywords":["Blau Farmac\u00eautica (BLAU3)","Especialistas","Hypera Pharma (HYPE3)","XP Investimentos"],"articleSection":["Neg\u00f3cios"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/www.suno.com.br\/noticias\/xp-recomenda-compra-hypera-hype3-blau-blau3\/","url":"https:\/\/www.suno.com.br\/noticias\/xp-recomenda-compra-hypera-hype3-blau-blau3\/","name":"XP recomenda compra da Hypera, mas a \"prefer\u00eancia \u00e9 pela Blau\"","isPartOf":{"@id":"https:\/\/www.suno.com.br\/noticias\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.suno.com.br\/noticias\/xp-recomenda-compra-hypera-hype3-blau-blau3\/#primaryimage"},"image":{"@id":"https:\/\/www.suno.com.br\/noticias\/xp-recomenda-compra-hypera-hype3-blau-blau3\/#primaryimage"},"thumbnailUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/04\/49d5915e-about-3887433_1280-jpg.webp","datePublished":"2021-06-04T18:46:16+00:00","description":"A XP inicia a cobertura do setor farmac\u00eautico brasileiro, com recomenda\u00e7\u00e3o de compra para a Blau (BLAU3) e Hypera (HYPE3). Clique e saiba mais","breadcrumb":{"@id":"https:\/\/www.suno.com.br\/noticias\/xp-recomenda-compra-hypera-hype3-blau-blau3\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.suno.com.br\/noticias\/xp-recomenda-compra-hypera-hype3-blau-blau3\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.suno.com.br\/noticias\/xp-recomenda-compra-hypera-hype3-blau-blau3\/#primaryimage","url":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/04\/49d5915e-about-3887433_1280-jpg.webp","contentUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/04\/49d5915e-about-3887433_1280-jpg.webp","width":1280,"height":853,"caption":"F\u00e1rmaco. Foto: Pixabay"},{"@type":"BreadcrumbList","@id":"https:\/\/www.suno.com.br\/noticias\/xp-recomenda-compra-hypera-hype3-blau-blau3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Not\u00edcias","item":"https:\/\/www.suno.com.br\/noticias\/"},{"@type":"ListItem","position":2,"name":"Neg\u00f3cios","item":"https:\/\/www.suno.com.br\/noticias\/negocios\/"},{"@type":"ListItem","position":3,"name":"XP recomenda compra da Hypera (HYPE3), mas a &#8220;prefer\u00eancia \u00e9 pela Blau&#8221; (BLAU3)"}]},{"@type":"WebSite","@id":"https:\/\/www.suno.com.br\/noticias\/#website","url":"https:\/\/www.suno.com.br\/noticias\/","name":"Suno Not\u00edcias","description":"Seu portal de informa\u00e7\u00e3o sobre o mundo dos investimentos","publisher":{"@id":"https:\/\/www.suno.com.br\/noticias\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.suno.com.br\/noticias\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/www.suno.com.br\/noticias\/#organization","name":"Suno Not\u00edcias","url":"https:\/\/www.suno.com.br\/noticias\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/","url":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png","contentUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png","width":180,"height":180,"caption":"Suno Not\u00edcias"},"image":{"@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/facebook.com\/sunoresearch","https:\/\/x.com\/sunoresearch","https:\/\/www.instagram.com\/suno","https:\/\/www.linkedin.com\/company\/suno-research\/","https:\/\/www.youtube.com\/c\/sunoresearch"]},{"@type":"Person","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/3df0d2808748b74496efe5dbeaef2c72","name":"Laura Moutinho","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7571c7c8ca3a6fca5e41384ece5557ff?s=96&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7571c7c8ca3a6fca5e41384ece5557ff?s=96&r=g","caption":"Laura Moutinho"},"description":"Estagi\u00e1ria na Suno Not\u00edcias, escreve not\u00edcias que afetam o mercado financeiro. Estuda administra\u00e7\u00e3o na Universidade Presbiteriana Mackenzie.","url":"https:\/\/www.suno.com.br\/noticias\/author\/laura-moutinho\/"}]}},"default_loop_html":"<div class=\"cardsPage__listCard__boxs\"><div class=\"cardsPage__listCard__boxs__img\"><a href=\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-lucro-1t21\/\"><img class=\"mask\" src=\"https:\/\/www.suno.com.br\/noticias\/wp-content\/themes\/suno\/resources\/images\/spotlight\/spotlight1img\/bg-mask.png\" alt=\"Image Mask\"\/><img src=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/03\/a651c83b-hypera.jpg-400x200.webp\" alt=\"Hypera Pharma (HYPE3): lucro l\u00edquido sobe 28,1% no 1T21 para R$ 305,1 mi\"\/><\/a><span class=\"spotlightCategory\"><a href=\"https:\/\/www.suno.com.br\/noticias\/negocios\/\">Neg\u00f3cios<\/a><\/span><\/div><div class=\"cardsPage__listCard__boxs__content\"><a href=\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-lucro-1t21\/\"><h2 class=\"content__title\">Hypera Pharma (HYPE3): lucro l\u00edquido sobe 28,1% no 1T21 para R$ 305,1 mi<\/h2><\/a><div class=\"newsContent__article__meta\"><div class=\"newsContent__article__meta__authorBox\"><a href=\"https:\/\/www.suno.com.br\/noticias\/author\/laura-moutinho\/\" class=\"authorBox__avatar noMobi\"><img src=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2020\/08\/531ff69d-whatsapp-image-2020-08-03-at-14.54.38-150x150.webp\" alt=\"Laura Moutinho\"><\/a><div class=\"authorBox__name\"><span>por\n\t\t\t<a href=\"https:\/\/www.suno.com.br\/noticias\/author\/laura-moutinho\/\"><span itemprop=\"author\">Laura Moutinho<\/span><\/a><\/span><time datetime=\"2021-04-23T20:03:22-03:00\" itemprop=\"datePublished\">23\/04\/2021 20:03<\/time><\/div><\/div><\/div><\/div><\/div>","single_layout":"posts","amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/posts\/154538"}],"collection":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/users\/39"}],"replies":[{"embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/comments?post=154538"}],"version-history":[{"count":2,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/posts\/154538\/revisions"}],"predecessor-version":[{"id":154554,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/posts\/154538\/revisions\/154554"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/media\/137378"}],"wp:attachment":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/media?parent=154538"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/categories?post=154538"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/tags?post=154538"},{"taxonomy":"suno_strategy","embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/suno_strategy?post=154538"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}